These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 30981753)

  • 1. Design and Synthesis of Galactose-Biotin Lipid Materials for Liposomes to Promote the Hepatoma Cell-Targeting Effect.
    Ding R; Li Z; Wang J; Zhu X; Zhao Z; Wang M
    J Pharm Sci; 2019 Sep; 108(9):3074-3081. PubMed ID: 30981753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Curcumin-loaded liposomes with the hepatic and lysosomal dual-targeted effects for therapy of hepatocellular carcinoma.
    Wang Y; Ding R; Zhang Z; Zhong C; Wang J; Wang M
    Int J Pharm; 2021 Jun; 602():120628. PubMed ID: 33892061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asialoglycoprotein receptor-targeted liposomes loaded with a norcantharimide derivative for hepatocyte-selective targeting.
    Liu X; Han M; Xu J; Geng S; Zhang Y; Ye X; Gou J; Yin T; He H; Tang X
    Int J Pharm; 2017 Mar; 520(1-2):98-110. PubMed ID: 28167263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reductively degradable α-amino acid-based poly(ester amide)-graft-galactose copolymers: facile synthesis, self-assembly, and hepatoma-targeting doxorubicin delivery.
    Lv J; Sun H; Zou Y; Meng F; Dias AA; Hendriks M; Feijen J; Zhong Z
    Biomater Sci; 2015 Jul; 3(7):1134-46. PubMed ID: 26221946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of galactose density on asialoglycoprotein receptor-mediated uptake of galactosylated liposomes.
    Managit C; Kawakami S; Yamashita F; Hashida M
    J Pharm Sci; 2005 Oct; 94(10):2266-75. PubMed ID: 16136555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Octanoyl galactose ester-modified microemulsion system self-assembled by coix seed components to enhance tumor targeting and hepatoma therapy.
    Qu D; Liu M; Huang M; Wang L; Chen Y; Liu C; Liu Y
    Int J Nanomedicine; 2017; 12():2045-2059. PubMed ID: 28352174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Galactosylated Poly(ethylene glycol)-Cholesterol for Liposomes as a Drug Carrier for Hepatocyte-Targeting.
    Zhang H; Xiao Y; Cui S; Zhou Y; Zeng K; Yan M; Zhao C
    J Nanosci Nanotechnol; 2015 Jun; 15(6):4058-69. PubMed ID: 26369013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of gal/GalNAc regioisomerism in galactosylated liposomes on asialoglycoprotein receptor-mediated hepatocyte-selective targeting
    Nie H; Qiu B; Yang QX; Zhao Y; Liu XM; Zhang YT; Liao FL; Zhang SY
    J Liposome Res; 2021 Mar; 31(1):79-89. PubMed ID: 31691619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocyte-targeting gene delivery using a lipoplex composed of galactose-modified aromatic lipid synthesized with click chemistry.
    Sakashita M; Mochizuki S; Sakurai K
    Bioorg Med Chem; 2014 Oct; 22(19):5212-9. PubMed ID: 25155912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation of novel butyryl galactose ester-modified coix component microemulsions and evaluation on hepatoma-targeting in vitro and in vivo.
    Liu MJ; Qu D; Chen Y; Liu CY; Liu YP; Ding XF
    Drug Deliv; 2016 Nov; 23(9):3444-3451. PubMed ID: 27198659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel PEG-matrix metalloproteinase-2 cleavable peptide-lipid containing galactosylated liposomes for hepatocellular carcinoma-selective targeting.
    Terada T; Iwai M; Kawakami S; Yamashita F; Hashida M
    J Control Release; 2006 Apr; 111(3):333-42. PubMed ID: 16488046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Asialoglycoprotein receptor-mediated gene transfer using novel galactosylated cationic liposomes.
    Kawakami S; Yamashita F; Nishikawa M; Takakura Y; Hashida M
    Biochem Biophys Res Commun; 1998 Nov; 252(1):78-83. PubMed ID: 9813149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Galactose Modified Liposomes for Effective Co-Delivery of Doxorubicin and Combretastatin A4.
    Lian B; Wei H; Pan R; Sun J; Zhang B; Wu J; Li X; Tian G
    Int J Nanomedicine; 2021; 16():457-467. PubMed ID: 33488080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design of cholesterol arabinogalactan anchored liposomes for asialoglycoprotein receptor mediated targeting to hepatocellular carcinoma: In silico modeling, in vitro and in vivo evaluation.
    Pathak P; Dhawan V; Magarkar A; Danne R; Govindarajan S; Ghosh S; Steiniger F; Chaudhari P; Gopal V; Bunker A; Róg T; Fahr A; Nagarsenker M
    Int J Pharm; 2016 Jul; 509(1-2):149-158. PubMed ID: 27231122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholesterol anchored arabinogalactan for asialoglycoprotein receptor targeting: synthesis, characterization, and proof of concept of hepatospecific delivery.
    Pathak PO; Nagarsenker MS; Barhate CR; Padhye SG; Dhawan VV; Bhattacharyya D; Viswanathan CL; Steiniger F; Fahr A
    Carbohydr Res; 2015 May; 408():33-43. PubMed ID: 25841057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Galactose-installed photo-crosslinked pH-sensitive degradable micelles for active targeting chemotherapy of hepatocellular carcinoma in mice.
    Zou Y; Song Y; Yang W; Meng F; Liu H; Zhong Z
    J Control Release; 2014 Nov; 193():154-61. PubMed ID: 24852094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of 11-DGA-3-
    Zhou L; Zou M; Zhu K; Ning S; Xia X
    Molecules; 2019 Aug; 24(17):. PubMed ID: 31450608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of hydrophile-lipophile balance of the linker in Gal/GalNAc ligands on high-affinity binding of galactosylated liposomes by the asialoglycoprotein receptor.
    Nie H; Liu XM; Yang QX; Luo XD; Zhao Y; Zhang SY
    Int J Pharm; 2022 Aug; 624():121967. PubMed ID: 35777585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In Vitro and In Vivo Evaluation of SP94 Modified Liposomes Loaded with N-14NCTDA, a Norcantharimide Derivative for Hepatocellular Carcinoma-Targeting.
    Jiang Y; Liu X; Tan X; Hou Y; Sun W; Gou J; Yin T; He H; Zhang Y; Tang X
    AAPS PharmSciTech; 2020 Oct; 21(7):277. PubMed ID: 33033942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Galactose-modified cationic liposomes as a liver-targeting delivery system for small interfering RNA.
    Sonoke S; Ueda T; Fujiwara K; Kuwabara K; Yano J
    Biol Pharm Bull; 2011; 34(8):1338-42. PubMed ID: 21804229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.